Form 483

Morgan Gallacher Form 483, 2019-08-23

FDA issued a Form 483 to Morgan Gallacher on 2019-08-23 with 8 public-safe observations.

483· Form 483 issuedHuman Drugs8 observations

Morgan Gallacher · Santa Fe Springs, United States · Issued August 23, 2019

Overview

  • 8 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

23 Aug 2019
21 CFR 211.115(a)

Reprocessing procedures lack steps to be taken

Cited by Santiago Gallardo Johnson

23 Aug 2019
21 CFR 211.115(a)

Reprocessing procedures lack steps to be taken

Cited by Santiago Gallardo Johnson

23 Aug 2019
21 CFR 211.165(f)

Failing drug products not rejected

Cited by Santiago Gallardo Johnson

23 Aug 2019
21 CFR 211.165(f)

Failing drug products not rejected

Cited by Santiago Gallardo Johnson

23 Aug 2019
21 CFR 211.180(e)(2)

Items to cover on annual reviews

Cited by Santiago Gallardo Johnson

Inspected site

MGMorgan GallacherSanta Fe Springs, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.115(a)Cited across public-safe Form 483 observations2x
21 CFR 211.165(f)Cited across public-safe Form 483 observations2x
21 CFR 211.180(e)(2)Cited across public-safe Form 483 observations2x
21 CFR 211.68(b)Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 8 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere